Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("infliximab")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 2035

  • Page / 82
Export

Selection :

  • and

Infliximab treatment of sarcoidosisSERIO, Ryan N.The Annals of pharmacotherapy. 2003, Vol 37, Num 4, pp 577-581, issn 1060-0280, 5 p.Article

InfliximabGOUJON, C; BACHELEZ, H.Annales de dermatologie et de vénéréologie. 2011, Vol 138, Num 12, pp 839-841, issn 0151-9638, 3 p.Article

Infliximab treatment for resistant Achilles tendonitisAL-ASFAR, Said M; ATTAR, Mohammad; SHACFEH, Hasan et al.Saudi medical journal. 2009, Vol 30, Num 9, pp 1228-1230, issn 0379-5284, 3 p.Article

Psoriasis blaschko-linéaire révélé par un traitement par infliximab (Remicade®) = Blasch-kolinear psoriasis revealed by infliximab therapySFIA, M; ROTH-MALL, B; TORTEL, M.-C et al.Annales de dermatologie et de vénéréologie. 2009, Vol 136, Num 12, pp 898-903, issn 0151-9638, 6 p.Article

Neurosarcoïdose réfractaire et infliximab : une expérience grandissante = Refractory neurosarcoidosis and infliximab : A growing experienceRITZENTHALER, T; GONZALEZ-MARTINEZ, V; GUEGEN, A et al.Revue neurologique (Paris). 2009, Vol 165, Num 2, pp 197-200, issn 0035-3787, 4 p.Article

Switching between antitumour necrosis factor alpha biologic agents -is patient weight an important consideration?DOWNS, A. M. R.British journal of dermatology (1951). 2009, Vol 160, Num 5, pp 1123-1124, issn 0007-0963, 2 p.Article

Frequency and Effectiveness of Dose Increase of Adalimumab, Etanercept, and Infliximab in Daily Clinical PracticeBLOM, M; KIEVIT, W; KUPER, H. H et al.Arthritis care and research. 2010, Vol 62, Num 9, pp 1335-1341, issn 0893-7524, 7 p.Article

Persistent Expression of CD26/DPPIV After Treatment with Infliximab in Psoriasis Despite Clinical ImprovementVAN LINGEN, Rosanne G; VAN ERP, Piet E. J; SEYGER, Marieke M. B et al.Acta dermato-venereologica. 2009, Vol 89, Num 5, pp 518-520, issn 0001-5555, 3 p.Article

Efficacy of infliximab in a patient with refractory idiopathic retroperitoneal fibrosisCATANOSO, M. G; SPAGGIARI, L; MAGNANI, L et al.Clinical and experimental rheumatology (Testo stampato). 2012, Vol 30, Num 5, pp 776-778, issn 0392-856X, 3 p.Article

Efficacy of infliximab in extrapulmonary sarcoidosis : results from a randomised trial. EditorialJUDSON, M. A; BAUGHMAN, R. P; COSTABE, U et al.The European respiratory journal. 2008, Vol 31, Num 6, issn 0903-1936, 1148-1149, 1189-1196 [10 p.]Article

Idiopathic lobular panniculitis: remission induced and maintained with infliximabAL-NIAIMI, F; CLARK, C; THORRAT, A et al.British journal of dermatology (1951). 2009, Vol 161, Num 3, pp 691-692, issn 0007-0963, 2 p.Article

Neurosarcoïdose et mycophénolate mofétil = Neurosarcoidosis treated with mycophenolate mofetil : two casesCHAUSSENOT, A; BOURG, V; CHANALET, S et al.Revue neurologique (Paris). 2007, Vol 163, Num 4, pp 471-475, issn 0035-3787, 5 p.Article

Therapy for extrapulmonary sarcoidosisBAUGHMAN, Robert P; LOWER, Elyse E.Seminars in respiratory and critical care medicine. 2002, Vol 23, Num 6, pp 589-596, issn 1069-3424, 8 p.Article

Short course of infliximab for disfiguring lupus pernioKIORPELIDOU, Despoina; GAITANIS, George; ZIOGA, Aikaterini et al.EJD. European journal of dermatology. 2008, Vol 18, Num 6, pp 727-729, issn 1167-1122, 3 p.Article

Infliximab in graft-versus-host diseaseRIVKINA, Anastasia M; STUMP, Lisa S.American journal of health-system pharmacy. 2002, Vol 59, Num 13, pp 1271-1275, issn 1079-2082Article

Efficacy of Intraarticular Infliximab in Patients With Chronic or Recurrent Gonarthritis: A Clinical Randomized TrialVAN DER BIJL, A. E; TENG, Y. K. O; VAN OOSTERHOUT, M et al.Arthritis care and research. 2009, Vol 61, Num 7, pp 974-978, issn 0893-7524, 5 p.Article

Worse patient VAS occurs at weeks 7 and 8 after infliximab infusionsSHENKER, N; HAIGH, R; CLARKE, A et al.Annals of the rheumatic diseases. 2005, Vol 64, Num 3, pp 502-503, issn 0003-4967, 2 p.Article

Refractory neurosarcoidosis responsive to infliximabKOBYLECKI, Christopher; SHAUNAK, Sandip.Practical neurology (Print). 2007, Vol 7, Num 2, pp 112-115, issn 1474-7758, 4 p.Article

Antibodies to constant domains of therapeutic monoclonal antibodies: Anti-hinge antibodies in immunogenicity testingRISPENS, Theo; DE VRIEZE, Henk; DE GROOT, Els et al.Journal of immunological methods. 2012, Vol 375, Num 1-2, pp 93-99, issn 0022-1759, 7 p.Article

Treatment of refractory neurosarcoidosis with InfliximabSANTOS, Ernestina; SHAUNAK, Sandip; RENOWDEN, Shelley et al.Journal of neurology, neurosurgery and psychiatry. 2010, Vol 81, Num 3, pp 241-246, issn 0022-3050, 6 p.Article

IgG1 heavy chain-coding gene polymorphism (G1m allotypes) and development of antibodies-to-infliximabMAGDELAINE-BEUZELIN, Charlotte; VERMEIRE, Séverine; RUTGEERTS, Paul et al.Pharmacogenetics and genomics (Print). 2009, Vol 19, Num 5, pp 383-387, issn 1744-6872, 5 p.Article

Wells' syndrome (eosinophilic cellulitis) secondary to infliximabTUGNET, Nicola; YOUSSEF, Amgad; WHALLETT, Andrew J et al.Rheumatology (Oxford. Print). 2012, Vol 51, Num 1, pp 195-196, issn 1462-0324, 2 p.Article

Efficacy of Infliximab on the acute attack of uveitisALOKAILY, Fahdah; ALSALEH, Sulaiman; AL-BALAWI, Maryseon et al.Saudi medical journal. 2010, Vol 31, Num 1, pp 82-85, issn 0379-5284, 4 p.Article

Occurrence of Plantar Pustular Psoriasis during Treatment with InfliximabENGLISH, Penny Lovell; VENDER, Ronald.Journal of cutaneous medicine and surgery. 2009, Vol 13, Num 1, pp 40-42, issn 1203-4754, 3 p.Article

Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetilMORAVAN, Michael; SEGAL, Benjamin M.Neurology. 2009, Vol 72, Num 4, pp 337-340, issn 0028-3878, 4 p.Article

  • Page / 82